(Q40615395)

22 September 2017

title

Alpha-1-antitrypsin expression in the lung is increased by airway delivery of gene-transfected macrophages (English)

1 reference

22 September 2017

Zhang D

1

1 reference

22 September 2017

Wu M

2

1 reference

22 September 2017

Nelson DE

3

1 reference

22 September 2017

Pasula R

4

1 reference

22 September 2017

Martin WJ 2nd

5

1 reference

22 September 2017

publication date

1 December 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

10

1 reference

22 September 2017

issue

26

1 reference

22 September 2017

page(s)

2148-2152

1 reference

Alpha1-antitrypsin deficiency--a model for conformational diseases

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Alpha1-antitrypsin deficiency: biological answers to clinical questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

The direct medical costs of alpha(1)-antitrypsin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Asialofetuin liposome-mediated human alpha1-antitrypsin gene transfer in vivo results in stationary long-term gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Gene therapy in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Gene therapy progress and prospects: alpha-1 antitrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Genetically engineered macrophages expressing IFN-gamma restore alveolar immune function in scid mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

A helper virus-free packaging system for recombinant adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Neutrophil lysosomal dysfunctions in mutant C57 Bl/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Long-term augmentation therapy in twenty patients with severe alpha-1-antitrypsin deficiency--three-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Cell-specific involvement of HNF-1beta in alpha(1)-antitrypsin gene expression in human respiratory epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

The intrapulmonary half-life and safety of aerosolized alpha1-protease inhibitor in normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Pulmonary epithelial expression of human alpha1-antitrypsin in transgenic mice results in delivery of alpha1-antitrypsin protein to the interstitium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Morphologic detection and functional assessment of reconstituted normal alveolar macrophages in the lungs of SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

7 January 2021

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

7 January 2021

Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

7 January 2021

Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

7 January 2021

Alpha-1 antitrypsin response of stimulated alveolar macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302121

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302121

1 reference

Dimensions Publication ID

22 September 2017

1030405098

0 references

1 reference